Freeze-dried Human Rabies Vaccine - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Freeze-dried Human Rabies Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Freeze-dried Human Rabies Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Freeze-dried Human Rabies Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report studies and analyses global Freeze-dried Human Rabies Vaccine status and future trends, helps the client to determine the Freeze-dried Human Rabies Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Freeze-dried Human Rabies Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Freeze-dried Human Rabies Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Freeze-dried Human Rabies Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Freeze-dried Human Rabies Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Freeze-dried Human Rabies Vaccine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Freeze-dried Human Rabies Vaccine key producing regions, capacity, production, and year over year growth
(6) Freeze-dried Human Rabies Vaccine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Sanofi Pasteur SA
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-vaccine
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Market segment by Type, covers
Vero Cells
Human Diploid Cells
Other
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Freeze-dried Human Rabies Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Freeze-dried Human Rabies Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Freeze-dried Human Rabies Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Freeze-dried Human Rabies Vaccine, percent & CAGR, 2018-2029
Chapter 5: Freeze-dried Human Rabies Vaccine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Freeze-dried Human Rabies Vaccine Definition
1.2 Global Freeze-dried Human Rabies Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Freeze-dried Human Rabies Vaccine Market Size，2018-2029
1.2.2 By Sales Quantity, Global Freeze-dried Human Rabies Vaccine Market Size，2018-2029
1.2.3 Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP)，2018-2029
1.3 China Freeze-dried Human Rabies Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Freeze-dried Human Rabies Vaccine Market Size，2018-2029
1.3.2 By Sales Quantity, China Freeze-dried Human Rabies Vaccine Market Size，2018-2029
1.3.3 China Freeze-dried Human Rabies Vaccine Average Selling Price (ASP)， 2018-2029
1.4 Share of China Freeze-dried Human Rabies Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Freeze-dried Human Rabies Vaccine Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Freeze-dried Human Rabies Vaccine Market Share in Global, 2018-2029
1.4.3 Freeze-dried Human Rabies Vaccine Market Size: China VS Global, 2018-2029
1.5 Freeze-dried Human Rabies Vaccine Market Dynamics
1.5.1 Freeze-dried Human Rabies Vaccine Market Drivers
1.5.2 Freeze-dried Human Rabies Vaccine Market Restraints
1.5.3 Freeze-dried Human Rabies Vaccine Industry Trends
1.5.4 Freeze-dried Human Rabies Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Freeze-dried Human Rabies Vaccine, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Freeze-dried Human Rabies Vaccine, Global Market Share by Company, 2018-2023
2.3 Freeze-dried Human Rabies Vaccine Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Freeze-dried Human Rabies Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Freeze-dried Human Rabies Vaccine Concentration Ratio
2.6 Global Freeze-dried Human Rabies Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Freeze-dried Human Rabies Vaccine Manufacturers Product Type
2.8 Head Office and Freeze-dried Human Rabies Vaccine Production Site of Key Manufacturer
2.9 Freeze-dried Human Rabies Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Freeze-dried Human Rabies Vaccine, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Freeze-dried Human Rabies Vaccine, China Market Share by Company, 2018-2023
3.3 China Freeze-dried Human Rabies Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Freeze-dried Human Rabies Vaccine Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Freeze-dried Human Rabies Vaccine Capacity by Region
4.3 Global Freeze-dried Human Rabies Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Freeze-dried Human Rabies Vaccine Production by Region, 2018-2029
4.5 Global Freeze-dried Human Rabies Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Freeze-dried Human Rabies Vaccine Industry Chain
5.2 Freeze-dried Human Rabies Vaccine Upstream Analysis
5.2.1 Freeze-dried Human Rabies Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Freeze-dried Human Rabies Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Freeze-dried Human Rabies Vaccine Production Mode
5.6 Freeze-dried Human Rabies Vaccine Procurement Model
5.7 Freeze-dried Human Rabies Vaccine Industry Sales Model and Sales Channels
5.7.1 Freeze-dried Human Rabies Vaccine Sales Model
5.7.2 Freeze-dried Human Rabies Vaccine Typical Distributors
6 Sights by Type
6.1 Freeze-dried Human Rabies Vaccine Classification
6.1.1 Vero Cells
6.1.2 Human Diploid Cells
6.1.3 Other
6.2 By Type, Global Freeze-dried Human Rabies Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029
6.4 By Type, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029
6.5 By Type, Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Freeze-dried Human Rabies Vaccine Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Freeze-dried Human Rabies Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029
7.4 By Application, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029
7.5 By Application, Global Freeze-dried Human Rabies Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029
8.3 By Region, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Freeze-dried Human Rabies Vaccine & Forecasts, 2018-2029
8.4.2 By Country, North America Freeze-dried Human Rabies Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Freeze-dried Human Rabies Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Freeze-dried Human Rabies Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Freeze-dried Human Rabies Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Freeze-dried Human Rabies Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Freeze-dried Human Rabies Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Freeze-dried Human Rabies Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Freeze-dried Human Rabies Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029
9.3 By Country, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.4.2 By Type, U.S. Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.5.2 By Type, Europe Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.6.2 By Type, China Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.7.2 By Type, Japan Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.8.2 By Type, South Korea Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.10.2 By Type, India Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Freeze-dried Human Rabies Vaccine Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Sanofi Pasteur SA
10.1.1 Sanofi Pasteur SA Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.1.3 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Sanofi Pasteur SA Company Profile and Main Business
10.1.5 Sanofi Pasteur SA Recent Developments
10.2 Guangzhou Nuocheng
10.2.1 Guangzhou Nuocheng Company Information, Head Office, Market Area, and Industry Position
10.2.2 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.2.3 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Guangzhou Nuocheng Company Profile and Main Business
10.2.5 Guangzhou Nuocheng Recent Developments
10.3 Ningbo Rong'an
10.3.1 Ningbo Rong'an Company Information, Head Office, Market Area, and Industry Position
10.3.2 Ningbo Rong'an Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.3.3 Ningbo Rong'an Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Ningbo Rong'an Company Profile and Main Business
10.3.5 Ningbo Rong'an Recent Developments
10.4 Hualan Bio-vaccine
10.4.1 Hualan Bio-vaccine Company Information, Head Office, Market Area, and Industry Position
10.4.2 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.4.3 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Hualan Bio-vaccine Company Profile and Main Business
10.4.5 Hualan Bio-vaccine Recent Developments
10.5 Bharat Biotech
10.5.1 Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
10.5.2 Bharat Biotech Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.5.3 Bharat Biotech Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Bharat Biotech Company Profile and Main Business
10.5.5 Bharat Biotech Recent Developments
10.6 Bavarian Nordic
10.6.1 Bavarian Nordic Company Information, Head Office, Market Area, and Industry Position
10.6.2 Bavarian Nordic Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.6.3 Bavarian Nordic Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bavarian Nordic Company Profile and Main Business
10.6.5 Bavarian Nordic Recent Developments
10.7 Serum Institute of India Pvt.
10.7.1 Serum Institute of India Pvt. Company Information, Head Office, Market Area, and Industry Position
10.7.2 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.7.3 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Serum Institute of India Pvt. Company Profile and Main Business
10.7.5 Serum Institute of India Pvt. Recent Developments
10.8 Chengdu Kanghua Biology
10.8.1 Chengdu Kanghua Biology Company Information, Head Office, Market Area, and Industry Position
10.8.2 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.8.3 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Chengdu Kanghua Biology Company Profile and Main Business
10.8.5 Chengdu Kanghua Biology Recent Developments
10.9 Changchun Zhuoyi Biology
10.9.1 Changchun Zhuoyi Biology Company Information, Head Office, Market Area, and Industry Position
10.9.2 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.9.3 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Changchun Zhuoyi Biology Company Profile and Main Business
10.9.5 Changchun Zhuoyi Biology Recent Developments
10.10 Dalian Yali Peak
10.10.1 Dalian Yali Peak Company Information, Head Office, Market Area, and Industry Position
10.10.2 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
10.10.3 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Dalian Yali Peak Company Profile and Main Business
10.10.5 Dalian Yali Peak Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Freeze-dried Human Rabies Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Freeze-dried Human Rabies Vaccine Market Restraints
Table 3. Freeze-dried Human Rabies Vaccine Market Trends
Table 4. Freeze-dried Human Rabies Vaccine Industry Policy
Table 5. Global Freeze-dried Human Rabies Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Freeze-dried Human Rabies Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Freeze-dried Human Rabies Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Freeze-dried Human Rabies Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Freeze-dried Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Freeze-dried Human Rabies Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Freeze-dried Human Rabies Vaccine Manufacturers Product Type
Table 13. Head Office and Freeze-dried Human Rabies Vaccine Production Site of Key Manufacturer
Table 14. Freeze-dried Human Rabies Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Freeze-dried Human Rabies Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Freeze-dried Human Rabies Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Freeze-dried Human Rabies Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Freeze-dried Human Rabies Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Freeze-dried Human Rabies Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Freeze-dried Human Rabies Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Freeze-dried Human Rabies Vaccine Upstream (Raw Materials)
Table 22. Global Freeze-dried Human Rabies Vaccine Typical Customers
Table 23. Freeze-dried Human Rabies Vaccine Typical Distributors
Table 24. By Type, Global Freeze-dried Human Rabies Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Freeze-dried Human Rabies Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Freeze-dried Human Rabies Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2018-2029
Table 34. Sanofi Pasteur SA Company Information, Head Office, Market Area, and Industry Position
Table 35. Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 36. Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Sanofi Pasteur SA Company Profile and Main Business
Table 38. Sanofi Pasteur SA Recent Developments
Table 39. Guangzhou Nuocheng Company Information, Head Office, Market Area, and Industry Position
Table 40. Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 41. Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Guangzhou Nuocheng Company Profile and Main Business
Table 43. Guangzhou Nuocheng Recent Developments
Table 44. Ningbo Rong'an Company Information, Head Office, Market Area, and Industry Position
Table 45. Ningbo Rong'an Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 46. Ningbo Rong'an Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Ningbo Rong'an Company Profile and Main Business
Table 48. Ningbo Rong'an Recent Developments
Table 49. Hualan Bio-vaccine Company Information, Head Office, Market Area, and Industry Position
Table 50. Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 51. Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Hualan Bio-vaccine Company Profile and Main Business
Table 53. Hualan Bio-vaccine Recent Developments
Table 54. Bharat Biotech Company Information, Head Office, Market Area, and Industry Position
Table 55. Bharat Biotech Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 56. Bharat Biotech Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Bharat Biotech Company Profile and Main Business
Table 58. Bharat Biotech Recent Developments
Table 59. Bavarian Nordic Company Information, Head Office, Market Area, and Industry Position
Table 60. Bavarian Nordic Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 61. Bavarian Nordic Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bavarian Nordic Company Profile and Main Business
Table 63. Bavarian Nordic Recent Developments
Table 64. Serum Institute of India Pvt. Company Information, Head Office, Market Area, and Industry Position
Table 65. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 66. Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Serum Institute of India Pvt. Company Profile and Main Business
Table 68. Serum Institute of India Pvt. Recent Developments
Table 69. Chengdu Kanghua Biology Company Information, Head Office, Market Area, and Industry Position
Table 70. Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 71. Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Chengdu Kanghua Biology Company Profile and Main Business
Table 73. Chengdu Kanghua Biology Recent Developments
Table 74. Changchun Zhuoyi Biology Company Information, Head Office, Market Area, and Industry Position
Table 75. Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 76. Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Changchun Zhuoyi Biology Company Profile and Main Business
Table 78. Changchun Zhuoyi Biology Recent Developments
Table 79. Dalian Yali Peak Company Information, Head Office, Market Area, and Industry Position
Table 80. Dalian Yali Peak Freeze-dried Human Rabies Vaccine Models, Specifications, and Application
Table 81. Dalian Yali Peak Freeze-dried Human Rabies Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Dalian Yali Peak Company Profile and Main Business
Table 83. Dalian Yali Peak Recent Developments
List of Figures
Figure 1. Freeze-dried Human Rabies Vaccine Picture
Figure 2. Global Freeze-dried Human Rabies Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Freeze-dried Human Rabies Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Freeze-dried Human Rabies Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Freeze-dried Human Rabies Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Freeze-dried Human Rabies Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Freeze-dried Human Rabies Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Freeze-dried Human Rabies Vaccine Market Share of Global, 2018-2029
Figure 10. Global Freeze-dried Human Rabies Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Freeze-dried Human Rabies Vaccine Key Participants, Market Share, 2022
Figure 12. Global Freeze-dried Human Rabies Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Freeze-dried Human Rabies Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Freeze-dried Human Rabies Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Freeze-dried Human Rabies Vaccine Industry Chain
Figure 16. Freeze-dried Human Rabies Vaccine Procurement Model
Figure 17. Freeze-dried Human Rabies Vaccine Sales Model
Figure 18. Freeze-dried Human Rabies Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Vero Cells
Figure 20. Human Diploid Cells
Figure 21. Other
Figure 22. By Type, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Hospital
Figure 28. Clinic
Figure 29. By Application, Global Freeze-dried Human Rabies Vaccine Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Freeze-dried Human Rabies Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2018-2029
Figure 36. North America Freeze-dried Human Rabies Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2022
Figure 38. Europe Freeze-dried Human Rabies Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2022
Figure 40. Asia Pacific Freeze-dried Human Rabies Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2022
Figure 42. South America Freeze-dried Human Rabies Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Freeze-dried Human Rabies Vaccine Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Freeze-dried Human Rabies Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|